黑料网

ISSN: 2161-1165

Epidemiology: 黑料网
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • Epidemiol Sci, Vol 11(8)

Diagnosis and Treatment of Craniopharyngioma in Brain Tumor

John Ogino*
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
*Corresponding Author: Dr. John Ogino, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Email: johnogino147@dfci.harvard.edu

Received: 10-Dec-2021 / Accepted Date: 24-Dec-2021 / Published Date: 31-Dec-2021

Description

Craniopharyngioma is a noncancerous (benign) brain tumour that is extremely rare.

The pituitary gland in the brain, which secretes hormones that govern a number of body functions, develops a craniopharyngioma near it. A craniopharyngioma can disrupt the function of the pituitary gland and other brain structures as it develops slowly..

Craniopharyngioma can affect anybody at any age, however it is more common in youngsters and the elderly. Progressive visual abnormalities, weariness, frequent urination, and headaches are some of the symptoms. Craniopharyngioma causes children to grow slowly and to be smaller than predicted.

Diagnosis

The following tests and methods are used to diagnose craniopharyngioma:

Physical exam- A medical history review and a neurological exam by your doctor are generally the first steps in diagnosing a craniopharyngioma. Your eyesight, hearing, balance, coordination, reflexes, and growth and development are all assessed during this examination.

Blood tests- Changes in hormone levels may be shown by blood tests, indicating that your pituitary gland is being affected by a tumour.

Imaging tests- X-rays, Magnetic Resonance Imaging (MRI), and computed tomography are some of the tests that may be used to obtain pictures of your brain (CT).

Treatment

Surgery- For persons with craniopharyngioma, surgery to remove all or most of the tumour is usually indicated. The sort of surgery required is determined on the location and size of your tumour.

The skull is opened to obtain access to the tumour in open craniopharyngioma surgery (craniotomy). Special surgical equipment are put via your nose during minimally invasive craniopharyngioma surgery (transsphenoidal operation). The instruments reach the tumour by a natural pathway, bypassing the brain.

Surgeons try to remove the entire tumour if at all feasible. However, because there are typically numerous sensitive and critical tissues nearby, surgeons don't always remove the entire tumour to guarantee a decent quality of life after surgery. Other therapies may be utilised following surgery in some cases.

Radiation therapy- After surgery, external beam radiation treatment may be used to treat craniopharyngioma. To destroy tumour cells, this therapy employs high-energy beams such as X-rays and protons. You lie on a table during external beam radiation therapy as a machine precisely targets the energy to the tumour cells.

External beam radiation technologies, such as proton therapy and Intensity-Modulated Radiation Therapy (IMRT), allows doctors to precisely shape and aim the radiation beam so that it treats tumour cells while sparing healthy tissue nearby.

When the tumour does not contact the bundle of nerve fibres that conveys vision information from your eye to your brain, a kind of radiation therapy called stereotactic radiosurgery may be indicated (optic nerve). Stereotactic radiosurgery, which is technically a form of radiation rather than an operation, concentrates numerous beams of radiation on specific places to destroy tumour cells.

Brachytherapy is a form of radiation therapy that includes injecting radioactive material directly into the tumour so that it can radiate from the inside.

Chemotherapy- Chemotherapy is a pharmacological treatment that kills tumour cells by using chemicals. Chemotherapy may be injected directly into the tumour, ensuring that the medication hits the target cells while causing no harm to healthy tissue surrounding.

Treatment for papillary craniopharyngioma- Papillary craniopharyngioma is a rare kind of craniopharyngioma that may respond to focused treatment. Targeted therapy is a type of medication treatment that targets specific defects in tumour cells that allow them to survive.

A mutation in the BRAF gene is seen in nearly all papillary craniopharyngioma cells. A therapeutic approach might be targeted therapy targeting at this mutation. If your craniopharyngioma comprises papillary cells, specialised laboratory testing can indicate if those cells have the BRAF gene mutation.

Clinical trials- Clinical trials are research investigations that look into novel medicines or new methods to use old ones. A clinical study allows you to try the most cutting-edge medicines, but the adverse effects may be unknown. Consult your doctor to see whether you're a candidate for clinical trials.

Citation: Ogino J (2021) Diagnosis and Treatment of Craniopharyngioma in Brain Tumor. Epidemiol Sci 11: 421.

Copyright: © 2021 Ogino J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top